Engineers Gate Manager’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-24,032
| Closed | -$3.17M | – | 2624 |
|
2025
Q1 | $3.17M | Buy |
24,032
+603
| +3% | +$79.5K | 0.05% | 504 |
|
2024
Q4 | $1.96M | Buy |
23,429
+3,095
| +15% | +$258K | 0.03% | 637 |
|
2024
Q3 | $1.49M | Buy |
20,334
+15,256
| +300% | +$1.12M | 0.03% | 788 |
|
2024
Q2 | $348K | Sell |
5,078
-1,074
| -17% | -$73.6K | 0.01% | 1386 |
|
2024
Q1 | $426K | Buy |
+6,152
| New | +$426K | 0.01% | 1282 |
|
2023
Q4 | – | Sell |
-47,003
| Closed | -$2.45M | – | 2319 |
|
2023
Q3 | $2.45M | Buy |
47,003
+7,335
| +18% | +$382K | 0.09% | 314 |
|
2023
Q2 | $2.51M | Buy |
39,668
+34,703
| +699% | +$2.2M | 0.1% | 279 |
|
2023
Q1 | $269K | Sell |
4,965
-2,727
| -35% | -$148K | 0.01% | 1308 |
|
2022
Q4 | $407K | Sell |
7,692
-13,231
| -63% | -$700K | 0.02% | 1021 |
|
2022
Q3 | $974K | Sell |
20,923
-19,671
| -48% | -$916K | 0.06% | 448 |
|
2022
Q2 | $2.32M | Buy |
40,594
+34,811
| +602% | +$1.99M | 0.08% | 304 |
|
2022
Q1 | $354K | Buy |
+5,783
| New | +$354K | 0.01% | 1285 |
|
2021
Q3 | – | Sell |
-27,816
| Closed | -$1.14M | – | 2039 |
|
2021
Q2 | $1.14M | Buy |
+27,816
| New | +$1.14M | 0.07% | 379 |
|
2020
Q4 | – | Sell |
-8,015
| Closed | -$206K | – | 2038 |
|
2020
Q3 | $206K | Buy |
+8,015
| New | +$206K | 0.01% | 1423 |
|
2020
Q1 | – | Sell |
-10,200
| Closed | -$350K | – | 1998 |
|
2019
Q4 | $350K | Sell |
10,200
-30,190
| -75% | -$1.04M | 0.02% | 1181 |
|
2019
Q3 | $302K | Buy |
40,390
+26,718
| +195% | +$200K | 0.02% | 1000 |
|
2019
Q2 | $177K | Sell |
13,672
-34,006
| -71% | -$440K | 0.01% | 1007 |
|
2019
Q1 | $581K | Buy |
47,678
+17,437
| +58% | +$212K | 0.04% | 575 |
|
2018
Q4 | $344K | Buy |
+30,241
| New | +$344K | 0.03% | 610 |
|
2018
Q2 | – | Sell |
-66,308
| Closed | -$1.4M | – | 1217 |
|
2018
Q1 | $1.4M | Buy |
66,308
+36,907
| +126% | +$777K | 0.09% | 368 |
|
2017
Q4 | $426K | Buy |
+29,401
| New | +$426K | 0.03% | 616 |
|